Cytidine Diphosphate-Choline (CDP-Choline) , Citicoline Powder CAS: 987-78-0 Cdpc

Name: Cytidine Diphosphate-Choline (CDP-Choline) , Citicoline Powder CAS: 987-78-0 Cdpc
Brand: Anhui GSH Bio-Technology Co., Ltd.
SKU: 2134982495

Anhui, ChinaAnhui GSH Bio-Technology Co., Ltd.

US$85.00-89.00

25 kg

Sample price:US$0.00/kg.Request sample

Product profile

Customization

Available

CAS No.

987-78-0

Formula

C14h27n4o11p2+

Model NO.

Cytidine Diphosphate-Choline

EINECS

213-580-7

Appearance

Powder

Quality

Refined

Colour

White

MSDS

Available

Usage

Nutrition Supplemtn for Brain Cells Health

Grade

Food Grade

Label

Can Be Customized

Transport Package

25kg/Drum, <25kg/Bag

Specification

>98%

Trademark

OEM

Origin

China

HS Code

2934999099

Production Capacity

400 Tons/Year

Company profile

Importers and ExportersHigh Repeat Buyers Choice100% Finished Products InspectionManagement Certification

Anhui GSH Bio-Technology Co., Ltd.

Anhui, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 8 Years CertifiedNearest Port: Shanghai PortAverage Response Time: ≤3.33h

AI-Powered supplier vetting

SummaryAnhui Gute Biotechnology Co., Ltd., also identified as Anhui GSH Bio-Technology Co., Ltd., is a China-based manufacturing company established in 2017. It reports three production lines, production bases in Jilin and Anhui, a third base planned for construction in 2023, 20 years of combined R&D engineer experience, and 21–30 quality-control staff. Its listed products include glutathione, NMN, citicoline sodium, CoQ10, and related ingredients, with stated output for several products. The supplier reports ISO9001:2015 and applications for BRCGS, HALAL, KOSHER, FSSC, HACCP, and FDA-related certifications. An SGS audit record is valid from June 20, 2025 to June 19, 2026, but the provided audit result value is not interpretable as a performance conclusion. Overseas service, detailed R&D services, customization, sustainability systems, and customer cases remain insufficiently evidenced.

Supplier typeThe supplier is explicitly identified as a factory and manufacturing enterprise in Anhui, China, with production bases in Anhui and Jilin and an integrated R&D, production, and sales model. This supports classification as a direct manufacturer rather than a trading-only entity.

CertificationsThe supplier explicitly reports an ISO9001:2015 certificate and lists applications for BRCGS, HALAL, KOSHER, FSSC, HACCP, and FDA-related certificates. An SGS audit record is also shown as valid from June 20, 2025 to June 19, 2026, although the supplied audit result value does not establish the audit outcome.

R&D capabilityThe supplier describes integrated R&D, production, and sales, 14 years of R&D experience, 19 declared Chinese invention patents, 2 declared international invention patents, 7 authorized Chinese invention patents, and 8 software copyrights. Nevertheless, specific professional-technical R&D, 3D design, SDK, new-product, and ODM capabilities are marked unknown.

Production capacityThe supplier reports three production lines, major production bases in Jilin and Anhui, a third base planned to begin construction in April 2023, and product output figures for citicoline sodium, glutathione, and NMN. These records provide explicit evidence of established production capacity and multi-site operations.